Results 231 to 240 of about 148,446 (303)

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Houston, we have a problem: Coagulation concerns during long‐term spaceflight

Experimental Physiology, EarlyView.
Lewis Fall, Damian M. Bailey
wiley   +1 more source

Immune endotypes in tuberculosis: Keys to decoding disease complexity

Journal of Internal Medicine, Volume 299, Issue 6, Page 670-693, June 2026.
Abstract Tuberculosis (TB) remains a major global health challenge, with multi‐drug antibiotic regimens as the current standard of care. While effective at killing Mycobacterium tuberculosis, these treatments do not resolve persistent inflammation, prevent lung damage, or reverse immune dysregulation that contribute to poor outcomes and disease ...
Shamila D. Alipoor, Julia Guthrie, Lina Davies Forsman, Andrew R. Di Nardo, Susanna Brighenti   +4 more
wiley   +1 more source

Risk factors for postoperative venous thromboembolism in patients with ovarian cancer. [PDF]

J Ovarian Res
Jia SR, Deng CH, Yimamu A, Liu J.
europepmc   +1 more source

Incidence of Venous Thromboembolism After Surgery for Acute Stanford Type A Aortic Dissection. [PDF]

Cureus
Saitoh M, Yamasaki T, Tanabe T, Tochigi S, Hirayama D, Aoyama K, Tei I.   +6 more
europepmc   +1 more source

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis

Arthritis &Rheumatology, Volume 78, Issue 5, Page 1176-1183, May 2026.
Objective Transition from long‐term denosumab (Dmab) to parathyroid hormone‐analogs or romosozumab (Romo) might expose patients to the risk of the so‐called rebound phenomenon. Adding Romo to Dmab might represent an option in patients experiencing a fracture while on Dmab.
Giovanni Adami, Francesco Pollastri, Angelo Fassio, Filippo Montanari, Anna Piccinelli, Camilla Benini, Emma Pasetto, Carmen Dartizio, Davide Gatti, Maurizio Rossini, Ombretta Viapiana   +10 more
wiley   +1 more source

The Necessity to Provide an Informed Choice Regarding Venous Thromboembolism Prophylaxis: A Single-Centre Study Observing Clinician Adherence and Opinions on Venous Thromboembolism Prophylaxis. [PDF]

Cureus
Patel U, Siddiqui IRA, Lodi A, Ziade G, Aziz I.   +4 more
europepmc   +1 more source

DOAC Score Versus HAS‐BLED and ORBIT for Predicting Bleeding Events in Atrial Fibrillation on Direct Oral Anticoagulants

Clinical Cardiology, Volume 49, Issue 5, May 2026.
ABSTRACT Background The comparative performance of the DOAC score versus established bleeding risk scores in patients with atrial fibrillation (AF) receiving direct oral anticoagulants (DOACs) remains uncertain. This meta‐analysis evaluated the predictive ability of the DOAC score compared with HAS‐BLED and ORBIT.
Yanfei Guo, Wengen Zhu, Qunfeng Ren
wiley   +1 more source

Safety and Feasibility of a CT‐Based Pathway for Left Atrial Appendage Assessment Prior to Inpatient Cardioversion: A Single‐Center Experience

Clinical Cardiology, Volume 49, Issue 5, May 2026.
An alternative for TEE? Cardiac CT is a practical alternative for ruling out LA/LAA thrombi in hospitalized patients who need cardioversion. ABSTRACT Background Transesophageal echocardiography (TEE) for left atrial appendage (LAA) thrombus exclusion before cardioversion faces logistical barriers including limited availability, patient intolerance, and
Ariel Furer, Maxim Perelman, Yafim Brodov, Orly Goitein, Sagit Ben Zikri, Rafael Kuperstein, Edward Itelman, Elad Maor, Eyal Nof, Roy Beinart, Shlomi Matetzky, Roy Beigel   +11 more
wiley   +1 more source

Monitoring anti-Xa levels and thromboelastography in puerperal venous thromboembolism: a prospective cohort study. [PDF]

Front Med (Lausanne)
Ma R, Tao W, Luo W, Zhou Y, Yu M, Xu Z.
europepmc   +1 more source